By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sunovion Pharmaceuticals Inc. 

84 Waterford Drive

Marlborough  Massachusetts  01752  U.S.A.
Phone: 508-481-6700 Fax:



Acadia  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.


Company News
Sunovion Pharmaceuticals Inc. Announces Results From A Study Evaluating The Abuse Potential Of Investigational Drug Dasotraline 1/25/2016 7:52:42 AM
SanBio, Inc. And Sunovion Pharmaceuticals Inc. Begin Patient Recruitment For Phase 2b Trial To Test Regenerative Treatment For Chronic Stroke In North America 12/21/2015 11:13:20 AM
Sunovion Pharmaceuticals Inc. Announces Results Of Health Outcomes Analyses Exploring The Effectiveness Of Aptiom (Eslicarbazepine Acetate) In People With Partial-Onset Seizures 12/7/2015 1:45:47 PM
Sunovion Pharmaceuticals Inc. To Present New Research And Data Analyses Supporting Use Of Aptiom (eslicarbazepine acetate) At The American Epilepsy Society 69th Annual Meeting 12/2/2015 10:50:27 AM
Sunovion Pharmaceuticals Inc. And The COPD Foundation Launch Reel COPD To Support Family Caregivers 11/9/2015 10:49:42 AM
Sunovion Pharmaceuticals Inc. To Present Health Outcomes Data Supporting Brovana® (Arformoterol Tartrate) Inhalation Solution In Patients With COPD At The 2015 American College of Chest Physicians Annual Meeting 10/19/2015 10:30:08 AM
Sunovion Pharmaceuticals Inc. Celebrates Five-Year Anniversary Milestone 10/15/2015 10:55:42 AM
Demi Lovato, Sunovion Pharmaceuticals Inc. And Leading Advocacy Organizations Call On Americans To Join Be Vocal Initiative By Speaking Up For Mental Health 10/5/2015 10:36:07 AM
PsychoGenics Inc. Extends Its Drug Discovery Collaboration With Sunovion Pharmaceuticals Inc. 9/14/2015 12:33:06 PM
Sunovion Pharmaceuticals Inc. Announces FDA Approval Of A New Indication For Aptiom (Eslicarbazepine Acetate) As Monotherapy For Partial-Onset Seizures 8/31/2015 11:27:38 AM